Monnens Y, Theodoropoulou A, Rosier K, Bhalla K, Mahy A, Vanhoutte R
JCI Insight. 2024; 9(17).
PMID: 39078710
PMC: 11385081.
DOI: 10.1172/jci.insight.179276.
Van Elzen R, Konijnenberg A, Van der Veken P, Edgeworth M, Scrivens J, Fulop V
J Med Chem. 2024; 67(12):10436-10446.
PMID: 38783480
PMC: 11215766.
DOI: 10.1021/acs.jmedchem.4c00866.
Lin S, Wu W, Cheng Y, Zhang J, Jiang D, Ren T
Exp Mol Med. 2023; 55(7):1437-1450.
PMID: 37394591
PMC: 10394032.
DOI: 10.1038/s12276-023-01027-8.
Kilpelainen T, Patsi H, Svarcbahs R, Julku U, Etelainen T, Cui H
J Med Chem. 2023; 66(11):7475-7496.
PMID: 37248563
PMC: 10258805.
DOI: 10.1021/acs.jmedchem.3c00235.
Zolotov N, Schepetkin I, Voronina T, Pozdnev V, Khlebnikov A, Krylova I
Front Chem. 2022; 9:780958.
PMID: 35004610
PMC: 8727363.
DOI: 10.3389/fchem.2021.780958.
Prolyl endopeptidase-like is a (thio)esterase involved in mitochondrial respiratory chain function.
Rosier K, McDevitt M, Smet J, Floyd B, Verschoore M, Marcaida M
iScience. 2021; 24(12):103460.
PMID: 34888501
PMC: 8634043.
DOI: 10.1016/j.isci.2021.103460.
Tetrazole as a Replacement of the Electrophilic Group in Characteristic Prolyl Oligopeptidase Inhibitors.
Kilpelainen T, Tyni J, Lahtela-Kakkonen M, Etelainen T, Myohanen T, Wallen E
ACS Med Chem Lett. 2019; 10(12):1635-1640.
PMID: 31857839
PMC: 6912865.
DOI: 10.1021/acsmedchemlett.9b00394.
Spatiotemporal expression and inhibition of prolyl oligopeptidase contradict its involvement in key pathologic mechanisms of kainic acid-induced temporal lobe epilepsy in rats.
Ali I, Van Eetveldt A, Van Elzen R, Raju T, Van der Veken P, Lambeir A
Epilepsia Open. 2019; 4(1):92-101.
PMID: 30868119
PMC: 6398098.
DOI: 10.1002/epi4.12293.
Removal of prolyl oligopeptidase reduces alpha-synuclein toxicity in cells and in vivo.
Svarcbahs R, Julku U, Norrbacka S, Myohanen T
Sci Rep. 2018; 8(1):1552.
PMID: 29367610
PMC: 5784134.
DOI: 10.1038/s41598-018-19823-y.
New compounds identified through in silico approaches reduce the α-synuclein expression by inhibiting prolyl oligopeptidase in vitro.
Kumar R, Bavi R, Jo M, Arulalapperumal V, Baek A, Rampogu S
Sci Rep. 2017; 7(1):10827.
PMID: 28883518
PMC: 5589771.
DOI: 10.1038/s41598-017-11302-0.
Dynamics and ligand-induced conformational changes in human prolyl oligopeptidase analyzed by hydrogen/deuterium exchange mass spectrometry.
Tsirigotaki A, Van Elzen R, Van der Veken P, Lambeir A, Economou A
Sci Rep. 2017; 7(1):2456.
PMID: 28550305
PMC: 5446394.
DOI: 10.1038/s41598-017-02550-1.
The expression of proline-specific enzymes in the human lung.
Vliegen G, Raju T, Adriaensen D, Lambeir A, De Meester I
Ann Transl Med. 2017; 5(6):130.
PMID: 28462210
PMC: 5395489.
DOI: 10.21037/atm.2017.03.36.
Prolyl oligopeptidase attenuates hepatic stellate cell activation through induction of Smad7 and PPAR-γ.
Zhou D, Wang J, He L, Li B, Ding Y, Chen Y
Exp Ther Med. 2017; 13(2):780-786.
PMID: 28352366
PMC: 5348651.
DOI: 10.3892/etm.2017.4033.
Mechanism of Action of Prolyl Oligopeptidase (PREP) in Degenerative Brain Diseases: Has Peptidase Activity Only a Modulatory Role on the Interactions of PREP with Proteins?.
Mannisto P, Garcia-Horsman J
Front Aging Neurosci. 2017; 9:27.
PMID: 28261087
PMC: 5306367.
DOI: 10.3389/fnagi.2017.00027.
Prolyl Oligopeptidase Regulates Dopamine Transporter Phosphorylation in the Nigrostriatal Pathway of Mouse.
Julku U, Panhelainen A, Tiilikainen S, Svarcbahs R, Tammimaki A, Piepponen T
Mol Neurobiol. 2016; 55(1):470-482.
PMID: 27966077
DOI: 10.1007/s12035-016-0339-8.
The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis.
Waumans Y, Baerts L, Kehoe K, Lambeir A, De Meester I
Front Immunol. 2015; 6:387.
PMID: 26300881
PMC: 4528296.
DOI: 10.3389/fimmu.2015.00387.
Prolyl oligopeptidase enhances α-synuclein dimerization via direct protein-protein interaction.
Savolainen M, Yan X, Myohanen T, Huttunen H
J Biol Chem. 2015; 290(8):5117-5126.
PMID: 25555914
PMC: 4335246.
DOI: 10.1074/jbc.M114.592931.
Hypothalamic prolyl endopeptidase (PREP) regulates pancreatic insulin and glucagon secretion in mice.
Kim J, Toda C, DAgostino G, Zeiss C, DiLeone R, Elsworth J
Proc Natl Acad Sci U S A. 2014; 111(32):11876-81.
PMID: 25071172
PMC: 4136568.
DOI: 10.1073/pnas.1406000111.
The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse.
Savolainen M, Richie C, Harvey B, Mannisto P, Maguire-Zeiss K, Myohanen T
Neurobiol Dis. 2014; 68:1-15.
PMID: 24746855
PMC: 7254878.
DOI: 10.1016/j.nbd.2014.04.003.
Prolyl endopeptidase-deficient mice have reduced synaptic spine density in the CA1 region of the hippocampus, impaired LTP, and spatial learning and memory.
DAgostino G, Kim J, Liu Z, Jeong J, Suyama S, Calignano A
Cereb Cortex. 2012; 23(8):2007-14.
PMID: 22767632
PMC: 3841400.
DOI: 10.1093/cercor/bhs199.